Last update: Jan. 15, 2020
Minimal risk for breastfeeding and infant.
A lincosamide antibacterial.
Administered orally, intramuscularly or intravenously in 3 to 4 daily dosis.
It is excreted in breastmilk in insignificant amounts (Zhang 1997, Matsuda 1984, Stéen 1982, Smith 1975) and no problems have been recorded in infants whose mothers were taking it, except occasional gastroenterocolitis due to alteration of the intestinal flora which clears a few days after treatment ends.
There is a published case (Mann 1980) of pseudomembranous colitis in an infant whose mother took clindamycin and gentamicin.
The possibility of transient gastroenteritis due to altered intestinal flora in infants whose mothers take antibiotics should be taken into account (Ito 1993).
Expert authors consider the use of this medication safe or probably safe during breastfeeding (Hale 2019, Briggs 2017, Amir 2014 y 2011, Mitrano 2009, Spencer 2008, Schaefer 2007).
American Academy of Pediatrics: medication usually compatible with breastfeeding (AAP 2001).
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) from Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM